---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-149822"
form_type: "8-K"
ticker: "ANTX"
cik: "0001880438"
company_name: "AN2 Therapeutics, Inc."
filed_at: "2026-04-09T23:59:59+00:00"
generated_at: "2026-05-15T06:49:29.739202+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# AN2 Therapeutics enters $80M ATM offering with Jefferies; prior ATM terminated

## Summary
- Entered into Open Market Sale Agreement with Jefferies to sell up to $80M of common stock at market prices.
- Jefferies receives up to 3.0% commission; offering may be terminated by either party on 10 days' notice.
- Terminated prior TD Cowen ATM under which 2,502,000 shares were sold for aggregate $20,016,251.
- Effective April 9, 2026; no shares have been sold yet under new agreement.

## SEC filing metadata
- accession: 0001193125-26-149822
- form_type: 8-K
- ticker: ANTX
- cik: 0001880438
- company_name: AN2 Therapeutics, Inc.
- filed_at: 2026-04-09T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1880438/000119312526149822/0001193125-26-149822-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1880438/000119312526149822/d127053d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-149822
- JSON: https://secwatch.observer/filing/0001193125-26-149822.json
- Plain text: https://secwatch.observer/filing/0001193125-26-149822.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.